• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高Gleason评分前列腺癌患者的血清白细胞单核细胞分数升高。

Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer.

作者信息

Hayashi Takuji, Fujita Kazutoshi, Tanigawa Go, Kawashima Atsunari, Nagahara Akira, Ujike Takeshi, Uemura Motohide, Takao Tetsuya, Yamaguchi Seiji, Nonomura Norio

机构信息

Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan.

Department of Urology, Osaka General Medical Center, Osaka, Japan.

出版信息

Oncotarget. 2017 May 23;8(21):35255-35261. doi: 10.18632/oncotarget.13052.

DOI:10.18632/oncotarget.13052
PMID:27823973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5471051/
Abstract

Systemic inflammation and immune responses are reported to be associated with progressive prostate cancer. In this study, we explored which among the fractions of white blood cell (WBC) and C-reactive protein (CRP) level were associated with high Gleason score prostate cancer. Prostate needle biopsy was performed in 966 men with suspicion of prostate cancer. We assessed age, serum prostate-specific antigen (PSA), prostate volume, WBC count, fractions of WBCs (neutrophils, lymphocytes, monocytes, basophils, and eosinophils), and CRP level before biopsy for associations with biopsy findings. Among all men, 553 (57.2%) were positive for prostate cancer including 421 with high Gleason score cancer (Gleason score ≥7). Age, PSA, PSA density (PSAD), serum monocyte fraction of WBC, monocyte-to-lymphocyte ratio (MLR), and CRP were significantly associated with high Gleason score cancer (p<0.01). Multivariate analysis showed that age, PSA, PSAD, and serum monocyte fraction were significantly associated with high Gleason score prostate cancer (p <0.01). In 571 patients with PSA of <10 ng/ml, age, PSA, PSAD, serum WBC count, neutrophil fraction, monocyte fraction, and MLR were significantly associated with high Gleason score prostate cancer (p<0.05). Multivariate analysis showed that age, PSAD, and serum monocyte fraction were significantly associated with high Gleason score prostate cancer (p<0.01). The monocyte fraction of WBCs was increased in patients with high Gleason score prostate cancer, suggesting an interaction of monocytes with the progression of prostate cancer.

摘要

据报道,全身炎症和免疫反应与前列腺癌进展有关。在本研究中,我们探讨了白细胞(WBC)各组分及C反应蛋白(CRP)水平中哪些与高 Gleason 评分前列腺癌相关。对 966 名疑似前列腺癌的男性进行了前列腺穿刺活检。我们在活检前评估了年龄、血清前列腺特异性抗原(PSA)、前列腺体积、白细胞计数、白细胞各组分(中性粒细胞、淋巴细胞、单核细胞、嗜碱性粒细胞和嗜酸性粒细胞)以及 CRP 水平,以确定其与活检结果的相关性。在所有男性中,553 例(57.2%)前列腺癌呈阳性,其中 421 例为高 Gleason 评分癌(Gleason 评分≥7)。年龄、PSA、PSA 密度(PSAD)、血清白细胞单核细胞组分、单核细胞与淋巴细胞比值(MLR)以及 CRP 与高 Gleason 评分癌显著相关(p<0.01)。多变量分析显示,年龄、PSA、PSAD 和血清单核细胞组分与高 Gleason 评分前列腺癌显著相关(p<0.01)。在 571 例 PSA<10 ng/ml 的患者中,年龄、PSA、PSAD、血清白细胞计数、中性粒细胞组分、单核细胞组分和 MLR 与高 Gleason 评分前列腺癌显著相关(p<0.05)。多变量分析显示,年龄、PSAD 和血清单核细胞组分与高 Gleason 评分前列腺癌显著相关(p<0.01)。高 Gleason 评分前列腺癌患者的白细胞单核细胞组分增加,提示单核细胞与前列腺癌进展存在相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a8/5471051/0db383d1e663/oncotarget-08-35255-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a8/5471051/0db383d1e663/oncotarget-08-35255-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a8/5471051/0db383d1e663/oncotarget-08-35255-g001.jpg

相似文献

1
Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer.高Gleason评分前列腺癌患者的血清白细胞单核细胞分数升高。
Oncotarget. 2017 May 23;8(21):35255-35261. doi: 10.18632/oncotarget.13052.
2
The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.前列腺特异性抗原(PSA)密度预测初始前列腺活检和前列腺切除术中 Gleason 评分升级的能力随着肿瘤分级的增加而降低,这是由于单位肿瘤体积的 PSA 分泌减少所致。
BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.
3
Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.基于当代多核心前列腺活检的前列腺特异性抗原与前列腺特异性抗原密度对诊断为 Gleason 6 前列腺癌患者升级的预测作用。
BJU Int. 2012 Dec;110(11 Pt B):E494-9. doi: 10.1111/j.1464-410X.2012.11182.x. Epub 2012 Apr 30.
4
Low serum neutrophil count predicts a positive prostate biopsy.低血清中性粒细胞计数预示着前列腺活检阳性。
Prostate Cancer Prostatic Dis. 2012 Dec;15(4):386-90. doi: 10.1038/pcan.2012.27. Epub 2012 Jul 10.
5
Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer.MRI 测算的前列腺体积与经体积校正的血清前列腺特异性抗原:与前列腺癌 Gleason 评分的相关性。
AJR Am J Roentgenol. 2013 Nov;201(5):1041-8. doi: 10.2214/AJR.13.10591.
6
[Total PSA, PSA density and biopsy Gleason score in predicting the pathologic stage of prostate cancer].[总前列腺特异性抗原、前列腺特异性抗原密度及活检Gleason评分在预测前列腺癌病理分期中的作用]
Zhonghua Nan Ke Xue. 2010 May;16(5):415-9.
7
Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.基于磁共振成像和前列腺特异性抗原密度的风险分层,可能会减少接受低风险前列腺癌主动监测的男性不必要的后续活检程序。
BJU Int. 2017 Oct;120(4):511-519. doi: 10.1111/bju.13836. Epub 2017 Apr 4.
8
Neutrophil-to-lymphocyte and neutrophil-to-monocyte rates in the decision for a prostate re-biopsy in patients with a previous benign pathology and consistently 2,5-10 ng/ml PSA value.既往病理结果为良性且前列腺特异性抗原(PSA)值持续在2.5 - 10 ng/ml的患者,在决定是否进行前列腺再次活检时的中性粒细胞与淋巴细胞比率及中性粒细胞与单核细胞比率。
Arch Esp Urol. 2016 Nov;69(9):627-635.
9
Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.在经直肠超声(TRUS)引导下穿刺活检 Gleason 评分 3 + 4 = 7 的前列腺癌患者中,筛状形态可预测根治性前列腺切除术后分期升级。
Virchows Arch. 2015 Oct;467(4):437-42. doi: 10.1007/s00428-015-1809-5. Epub 2015 Jul 31.
10
Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.前列腺癌患者的血清胰岛素水平、疾病分期、前列腺特异性抗原(PSA)和 Gleason 评分。
Br J Cancer. 2002 Sep 23;87(7):726-8. doi: 10.1038/sj.bjc.6600526.

引用本文的文献

1
NK Cell-Microbiota Interaction Biomarker Strategy: Advancing Prostate Cancer Management.自然杀伤细胞-微生物群相互作用生物标志物策略:推动前列腺癌管理
Biomolecules. 2025 Feb 13;15(2):273. doi: 10.3390/biom15020273.
2
Causal association of peripheral immune cell counts with risk of prostate cancer: insights from bidirectional Mendelian randomization.外周免疫细胞计数与前列腺癌风险的因果关联:双向孟德尔随机化研究的见解
Front Oncol. 2024 Nov 29;14:1374927. doi: 10.3389/fonc.2024.1374927. eCollection 2024.
3
Immunome profiling in prostate cancer: a guide for clinicians.

本文引用的文献

1
The influence of PSA autoantibodies in prostate cancer patients: a prospective clinical study-II.前列腺癌患者中前列腺特异性抗原自身抗体的影响:一项前瞻性临床研究-II。
Oncotarget. 2017 Mar 14;8(11):17643-17650. doi: 10.18632/oncotarget.12620.
2
Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer.岩藻糖基化前列腺特异性抗原降低作为高Gleason评分前列腺癌的尿液标志物
Oncotarget. 2016 Aug 30;7(35):56643-56649. doi: 10.18632/oncotarget.10987.
3
Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.
前列腺癌的免疫组库分析:临床医生指南
Front Immunol. 2024 Nov 20;15:1398109. doi: 10.3389/fimmu.2024.1398109. eCollection 2024.
4
Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio.探讨临床上显著的前列腺癌、肥胖与血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值之间的相关性。
BMC Urol. 2024 Oct 16;24(1):226. doi: 10.1186/s12894-024-01617-2.
5
Association between monocyte-to-lymphocyte ratio and prostate cancer in the U.S. population: a population-based study.美国人群中单核细胞与淋巴细胞比值和前列腺癌之间的关联:一项基于人群的研究。
Front Cell Dev Biol. 2024 Apr 5;12:1372731. doi: 10.3389/fcell.2024.1372731. eCollection 2024.
6
Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer.Pt-Mal-LHRH 针对三阴性乳腺癌的治疗剂量和靶向疗效。
PLoS One. 2023 Oct 10;18(10):e0287151. doi: 10.1371/journal.pone.0287151. eCollection 2023.
7
Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment.去势抵抗性前列腺癌(mCRPC)患者外周血免疫表型与镭-223治疗结局的相关性
Diagnostics (Basel). 2023 Jun 29;13(13):2222. doi: 10.3390/diagnostics13132222.
8
Clinical Predictors of Grade Group Upgrading for Radical Prostatectomy Specimens Compared to Those of Preoperative Needle Biopsy Specimens.与术前穿刺活检标本相比,根治性前列腺切除术标本分级组升级的临床预测因素。
Diagnostics (Basel). 2022 Nov 11;12(11):2760. doi: 10.3390/diagnostics12112760.
9
Monocyte programming by cancer therapy.癌症治疗对单核细胞的编程作用。
Front Immunol. 2022 Oct 20;13:994319. doi: 10.3389/fimmu.2022.994319. eCollection 2022.
10
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy.治疗前血红蛋白浓度和绝对单核细胞计数作为接受放疗的局限性或局部晚期前列腺癌患者生存的独立预后因素。
Biomedicines. 2022 Oct 8;10(10):2514. doi: 10.3390/biomedicines10102514.
低风险和高风险前列腺癌中包埋的Gleason 3级肿瘤腺体的基因表达分析。
Oncotarget. 2016 Jun 21;7(25):37846-37856. doi: 10.18632/oncotarget.9344.
4
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.主动监测在局限性前列腺癌管理中的应用(安大略癌症护理指南):美国临床肿瘤学会临床实践指南的认可。
J Clin Oncol. 2016 Jun 20;34(18):2182-90. doi: 10.1200/JCO.2015.65.7759. Epub 2016 Feb 16.
5
PSA and beyond: alternative prostate cancer biomarkers.前列腺特异性抗原及其他:前列腺癌替代生物标志物
Cell Oncol (Dordr). 2016 Apr;39(2):97-106. doi: 10.1007/s13402-016-0268-6. Epub 2016 Jan 20.
6
Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men.亚洲男性病理意义不显著前列腺癌主动监测标准的验证
Int J Urol. 2016 Jan;23(1):49-54. doi: 10.1111/iju.12952. Epub 2015 Oct 8.
7
Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy.中性粒细胞与淋巴细胞比值可预测接受穿刺活检男性的前列腺癌。
Oncotarget. 2015 Oct 13;6(31):32169-76. doi: 10.18632/oncotarget.5081.
8
Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB Activity.单核细胞诱导的前列腺癌细胞侵袭由趋化因子配体2和核因子κB活性介导。
J Clin Cell Immunol. 2015 Apr;6(2). doi: 10.4172/2155-9899.1000308.
9
An Elevated Peripheral Blood Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma.外周血单核细胞与淋巴细胞比值升高预示原发性肺淋巴上皮瘤样癌患者预后不良。
PLoS One. 2015 May 7;10(5):e0126269. doi: 10.1371/journal.pone.0126269. eCollection 2015.
10
Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14 PD-L1 phenotype in prostate cancer.肿瘤基质衍生因子使单核细胞向树突状细胞分化,并向前列腺癌中具有抑制性 CD14 PD-L1 表型的方向发展。
Oncoimmunology. 2014 Dec 13;3(9):e955331. doi: 10.4161/21624011.2014.955331. eCollection 2014 Oct.